Microbial Drug Resistance · 2000 · 21 citations · 11 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceImmunizationMedical MicrobiologyAntibiotic ResistanceBacterial EpidemiologyBacterial InfectionsRespiratory InfectionsRespiratory Tract InfectionsAntibiotic Susceptibility Data AnalysisAntibiotic Susceptibility TestingEpidemiology Of Bacterial InfectionsInvasive InfectionPneumococcal DiseaseSerotype Distribution
Antibiotic susceptibility patterns and serotypes of 397 Streptococcus pneumoniae recovered from 1994 to 1998 in Italy have been determined. This collection included 229 penicillin- and/or erythromycin-resistant strains and 168 isolates responsible for invasive infections. Among penicillin-resistant pneumococci, the most prevalent serotype was 23F, followed by 19F and 9V, while among erythromycin-resistant but penicillin-susceptible strains serotype 6B was predominant followed by 19A, 14, 19F, 15A, 15B, and 23F. The most common invasive serotypes were 6B, 19F, 23F, 3, 4, 14, 20, 15B, and 9N. The currently available 23-valent pneumococcal vaccine could cover 91% of noninvasive penicillin- and/or erythromycin-resistant strains, 84% of pneumococci isolated from sterile sites, and 83% of invasive antibiotic-resistant S. pneumoniae. Penicillin-resistant pneumococci also showed reduced susceptibility to other antimicrobial compounds. Against invasive pneumococci, amoxicillin, cefotaxime, ceftriaxone, imipenem, vancomycin, and rifampin were 100% effective. Penicillin, chloramphenicol, erythromycin, tetracycline, and co-trimoxazole resistance was 1.8%, 9.5%, 15.5%, 18.5%, and 21.4%, respectively.
11
Manual of Clinical Microbiology.
Annals of Internal Medicine · 1980 · 14.5K citations
Emergence of vancomycin tolerance in Streptococcus pneumoniae
Robert W. Novak, Birgitta Henriques, Emmanuelle Charpentier et al. · Nature · 1999 · 352 citations
Glenn Turett, Steve Blum, Barkat A. Fazal et al. · Clinical Infectious Diseases · 1999 · 158 citations · Full text